Aditya Vision Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 19, 2025, 4:06 am

Quick Insight

Aditya Vision Ltd, a player in the specialty non-apparel retail industry, currently trades at a price of 490 with a market cap of 6,308 Cr. The company's high P/E ratio of 58.6 suggests a premium valuation, supported by a robust ROE of 20.3% and ROCE of 19.1%. With a healthy OPM of 10% and a net profit of 106 Cr, Aditya Vision showcases operational efficiency. However, a high P/BV of 9.82x and significant borrowings of 480 Cr raise leverage concerns. The company's working capital cycle of 105 days indicates efficient management of liquidity. Overall, investors should closely monitor Aditya Vision's leverage levels and operational performance to gauge its sustainability in the long run.

Competitors of Aditya Vision Ltd

All Competitor Stocks of Aditya Vision Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:25 am

Below is a detailed analysis of the quarterly data for Aditya Vision Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 940.00 Cr.. The value appears strong and on an upward trend. It has increased from 487.00 Cr. (Mar 2025) to 940.00 Cr., marking an increase of 453.00 Cr..
• For Expenses, as of Jun 2025, the value is 850.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 444.00 Cr. (Mar 2025) to 850.00 Cr., marking an increase of 406.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 48.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 10.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 49.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 34.00% (Mar 2025) to 25.00%, marking a decrease of 9.00%.
• For Net Profit, as of Jun 2025, the value is 55.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 55.00 Cr., marking an increase of 39.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.29. The value appears strong and on an upward trend. It has increased from 1.24 (Mar 2025) to 4.29, marking an increase of 3.05.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:39 pm

Growth

Last Updated: September 5, 2025, 2:06 pm

Balance Sheet

Last Updated: September 10, 2025, 2:55 pm

Below is a detailed analysis of the balance sheet data for Aditya Vision Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 571.00 Cr.. The value appears strong and on an upward trend. It has increased from 474.00 Cr. (Mar 2024) to 571.00 Cr., marking an increase of 97.00 Cr..
• For Borrowings, as of Mar 2025, the value is 480.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 319.00 Cr. (Mar 2024) to 480.00 Cr., marking an increase of 161.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 159.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.00 Cr. (Mar 2024) to 159.00 Cr., marking an increase of 89.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,223.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 875.00 Cr. (Mar 2024) to 1,223.00 Cr., marking an increase of 348.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 268.00 Cr.. The value appears strong and on an upward trend. It has increased from 244.00 Cr. (Mar 2024) to 268.00 Cr., marking an increase of 24.00 Cr..
• For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 949.00 Cr.. The value appears strong and on an upward trend. It has increased from 622.00 Cr. (Mar 2024) to 949.00 Cr., marking an increase of 327.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 875.00 Cr. (Mar 2024) to 1,223.00 Cr., marking an increase of 348.00 Cr..

Notably, the Reserves (571.00 Cr.) exceed the Borrowings (480.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Aditya Vision Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 63.72 (Mar 24) to 8.21, marking a decrease of 55.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.16. This value is within the healthy range. It has decreased from 63.18 (Mar 24) to 8.16, marking a decrease of 55.02.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.08. This value is within the healthy range. It has decreased from 82.42 (Mar 24) to 11.08, marking a decrease of 71.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.38. It has decreased from 379.69 (Mar 24) to 45.38, marking a decrease of 334.31.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.38. It has decreased from 379.69 (Mar 24) to 45.38, marking a decrease of 334.31.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.10. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 1.10, marking a decrease of 13.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 175.72. It has decreased from 1,359.94 (Mar 24) to 175.72, marking a decrease of 1,184.22.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 16.47. This value is within the healthy range. It has decreased from 135.75 (Mar 24) to 16.47, marking a decrease of 119.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is 13.59. This value is within the healthy range. It has decreased from 113.45 (Mar 24) to 13.59, marking a decrease of 99.86.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.13. This value is within the healthy range. It has decreased from 83.21 (Mar 24) to 11.13, marking a decrease of 72.08.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.20. This value is within the healthy range. It has decreased from 60.12 (Mar 24) to 8.20, marking a decrease of 51.92.
• For PBDIT Margin (%), as of Mar 25, the value is 9.37. This value is below the healthy minimum of 10. It has decreased from 9.98 (Mar 24) to 9.37, marking a decrease of 0.61.
• For PBIT Margin (%), as of Mar 25, the value is 7.73. This value is below the healthy minimum of 10. It has decreased from 8.34 (Mar 24) to 7.73, marking a decrease of 0.61.
• For PBT Margin (%), as of Mar 25, the value is 6.33. This value is below the healthy minimum of 10. It has increased from 6.11 (Mar 24) to 6.33, marking an increase of 0.22.
• For Net Profit Margin (%), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from 4.42 (Mar 24) to 4.66, marking an increase of 0.24.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.07. This value is within the healthy range. It has increased from 15.83 (Mar 24) to 18.07, marking an increase of 2.24.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.86. This value is within the healthy range. It has increased from 21.84 (Mar 24) to 22.86, marking an increase of 1.02.
• For Return On Assets (%), as of Mar 25, the value is 8.62. This value is within the healthy range. It has decreased from 8.80 (Mar 24) to 8.62, marking a decrease of 0.18.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.47, marking an increase of 0.22.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.15. It has decreased from 2.34 (Mar 24) to 2.15, marking a decrease of 0.19.
• For Current Ratio (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has decreased from 2.80 (Mar 24) to 1.99, marking a decrease of 0.81.
• For Quick Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 24) to 0.46, marking a decrease of 0.27.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.18 (Mar 24) to 0.00, marking a decrease of 20.18.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.72 (Mar 24) to 0.00, marking a decrease of 14.72.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.82 (Mar 24) to 0.00, marking a decrease of 79.82.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.28 (Mar 24) to 0.00, marking a decrease of 85.28.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.68. This value is within the healthy range. It has increased from 4.49 (Mar 24) to 6.68, marking an increase of 2.19.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has increased from 2.99 (Mar 24) to 4.33, marking an increase of 1.34.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,886.14. It has increased from 4,433.81 (Mar 24) to 5,886.14, marking an increase of 1,452.33.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.60. This value is within the healthy range. It has increased from 2.54 (Mar 24) to 2.60, marking an increase of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 27.79. This value exceeds the healthy maximum of 15. It has increased from 25.48 (Mar 24) to 27.79, marking an increase of 2.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has increased from 2.53 (Mar 24) to 2.54, marking an increase of 0.01.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 79.81 (Mar 24) to 0.00, marking a decrease of 79.81.
• For Price / BV (X), as of Mar 25, the value is 9.82. This value exceeds the healthy maximum of 3. It has increased from 9.05 (Mar 24) to 9.82, marking an increase of 0.77.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has increased from 2.53 (Mar 24) to 2.54, marking an increase of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness